Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial.
BACKGROUND
Despite many investigations of sunscreen use, there have been few among adults in the community at large. Better understanding of sunscreen application patterns will lead to more strategic skin cancer prevention strategies among sun-exposed populations.


OBJECTIVE
To explore patterns of sunscreen use, particularly the quantity of sunscreen used and the application frequency, among participants in a community-based sunscreen intervention.


METHODS
Follow-up of patterns of sunscreen use over 4.5 years.


METHODS
Nambour, a subtropical town in Queensland, Australia.


METHODS
People drawn randomly from the electoral register who were later randomized as part of a skin cancer prevention trial.


METHODS
Daily application of a standard sun protection factor 15+ broad-spectrum retail sunscreen to the head and neck, arms, and hands.


METHODS
Frequency of application of sunscreen, weight of sunscreen applied, and quantity applied per unit area of skin.


RESULTS
Fifty-six percent of participants reported applying sunscreen on at least 5 days per week, with 27% using sunscreen infrequently on 2 or fewer days per week. The median daily amount of sunscreen applied averaged over the duration of the trial was 1.5 g/d (range, 0-7.4 g/d). The median quantity of sunscreen applied was 0.79 mg/cm(2), which was less than half the amount needed to achieve the labeled sun protection factor.


CONCLUSIONS
It is possible to implement the daily application of sunscreen in sun-exposed populations, although protection would be increased if the quantity of sunscreen applied were greater.
Neale
Rachel
R
Population and Clinical Sciences Division, Queensland Institute of Medical Research, Brisbane, Australia. rachelN@qimr.edu.au
Williams
Gail
G
Green
Adèle
A
D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000517:prevention & control*; D016001:Confidence Intervals; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D015438:Health Behavior; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011336:Probability; D011793:Queensland; D012878:Skin Neoplasms / Q000209:etiology / Q000517:prevention & control*; D013472:Sunlight / Q000009:adverse effects*; D013473:Sunscreening Agents / Q000008:administration & dosage*
D013473:Sunscreening Agents